AI
| Followers | 13 |
| Posts | 608 |
| Boards Moderated | 0 |
| Alias Born | 06/05/2015 |
Tuesday, March 01, 2016 10:32:42 AM
Thank you gpuppy- this is what I thought might have happened. This will have an effect on many current cancer trials across the board - won't it? BTW- My husband is an internist as well, but he has no interest in stock investments - well until this fiasco. Now he doesn't want me to look at a stock message board ever again and hand all money over to our investment advisor. Obviously I listen well - cause here I am reading/posting - 
What I'm unclear on is - where does this current predicament leave the company's short term financial situation? Can they recover from this situation without further shareholder destruction in the near term? This is why I'm 80% out on a huge loss. I believe in the science based on scientific publications and can see a demand in immunotherapy combo trials, but I'm unclear as to what this set-back will do to the company financially? Any thoughts? Wait a month, take the tax loss, let the dust settle?
What I'm unclear on is - where does this current predicament leave the company's short term financial situation? Can they recover from this situation without further shareholder destruction in the near term? This is why I'm 80% out on a huge loss. I believe in the science based on scientific publications and can see a demand in immunotherapy combo trials, but I'm unclear as to what this set-back will do to the company financially? Any thoughts? Wait a month, take the tax loss, let the dust settle?
